Tomorrow.bio’s latest update unveils a major expansion of our Standby, Stabilization & Transport (SST) operations throughout Europe. Building on established teams, we're proud to roll out our new custom-engineered ambulances for fast response.
These enhancements are part of our broader 2025 vision: to deepen coverage, improve emergency readiness, and ultimately ensure every member gets immediate, high-quality cryopreservation care. With this expansion, we are significantly enhancing our operational capacity to initiate rapid, on-site biostasis protocols, bridging the critical time window between legal death and the start of cryopreservation procedures.
The newly deployed ambulances are equipped with advanced cryopreservation technology, including systems for stabilization, whole-body field cryoprotection/perfusion, monitoring and transport under controlled low-temperature conditions, and seamless integration with our Switzerland-based preservation facilities.
Each unit will be strategically placed to reduce response times, improve logistical efficiency, and allow us to reach a greater number of members in emergency scenarios. These ambulances also enable our team to coordinate more effectively on the ground, ensuring a higher standard of readiness and efficiency during cases.
This deployment reflects our continued commitment to building a robust, continent-spanning infrastructure that supports reliable biostasis operations. By extending our reach, we are laying the groundwork for a future where long-term human preservation is not only possible, but accessible when and where it matters most.
Get ready for an insightful AMA with Dr. Emil Kendziorra—Entrepreneur and CEO of Tomorrow.bio, as well as Chairman of the European Biostasis Foundation. In this live session, he’ll be answering your burning questions about cryonics, suspended animation, and the future of biostasis. Dive into topics ranging from emergency situations to the science of human vitrification.
Be the first to RSVP for this AMA, which offers a great opportunity to engage directly with one of the field’s leading voices. Whether you're curious about the technical roadmap, ethical dimensions, or real-world applications of biostasis, Dr. Kendziorra is ready to share his expertise.
Dr. Kendziorra has been at the forefront of the cryonics field, leading the future of engineering. He co-founded Tomorrow Biostasis in Berlin to pioneer cryopreservation protocols that not only preserve bodies at legal death but could one day offer a shot at revival. You can expect to learn about the current state of research, regulatory and timeline considerations, and how to get involved to support our efforts.
This AMA is an essential watch for anyone interested in life extension, cryonics, and the future of full-body biostasis. Have your questions ready, and sign up at the link above.
A Suspended Animation Research Hierarchy
In his essay on Biostasis, researcher Brian Wowk, PhD., outlines a pragmatic hierarchy for suspended animation research, aiming to bring clarity and focus to a field often clouded by speculation. At the top are life-saving interventions—methods that can preserve and later revive human beings in critical condition, such as deep hypothermia in trauma care. Next come animal studies that demonstrate full biological recovery after metabolic stasis, providing essential proof-of-concept data. At the foundation lies exploratory work into the biological mechanisms that make suspended animation possible, such as molecular repair, oxygen tolerance, and cellular resilience.
Wowk’s framework isn’t just theoretical—it’s a call for strategic prioritization. By distinguishing between speculative curiosity and translational utility, the hierarchy encourages researchers and funders to target efforts where they’re most likely to yield clinical breakthroughs. In a field that straddles science fiction and life-saving potential, this model aims to ensure progress remains both grounded and goal-driven.
Researchers have developed a promising blood (or saliva) test that measures a person’s intrinsic capacity (IC) — the combined physical and mental abilities such as cognition, mobility, sensory function, psychological health, and vitality.
By analyzing DNA methylation patterns—chemical tags on genes—this “IC clock” predicts biological age and overall health, and is strongly linked to all‑cause mortality. In fact, individuals with high IC scores lived, on average, 5.5 years longer than those with lower scores.
Experts describe the test as accessible, noninvasive, and meaningful because it reflects how well you're actually aging, rather than just your chronological age. Associations with healthier aging patterns—like stronger lung function, faster walk speed, and better bone density—support its clinical potential.
Lifestyle elements also play a role: higher intake of oily fish and keeping sugar intake under 5% of calories were linked to better IC scores. While more research is needed before clinical use, the study suggests this test could help track aging and personalize interventions—such as diet, exercise, and mental engagement—to support healthier aging.
